$959 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 82 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $94,844,000 | – | 210,000 | +100.0% | 9.88% | – |
| XOP | New | SPDR SER TRs&p oilgas exp | $38,898,000 | – | 289,100 | +100.0% | 4.05% | – |
| AA | New | ALCOA CORP | $33,149,000 | – | 368,200 | +100.0% | 3.46% | – |
| CCK | New | CROWN HLDGS INC | $19,472,000 | – | 155,665 | +100.0% | 2.03% | – |
| REGN | New | REGENERON PHARMACEUTICALSput | $17,461,000 | – | 25,000 | +100.0% | 1.82% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $16,351,000 | – | 54,200 | +100.0% | 1.70% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $14,255,000 | – | 50,200 | +100.0% | 1.49% | – |
| AZEK | New | AZEK CO INCcl a | $12,867,000 | – | 518,000 | +100.0% | 1.34% | – |
| TNDM | New | TANDEM DIABETES CARE INCcall | $11,629,000 | – | 100,000 | +100.0% | 1.21% | – |
| AMN | New | AMN HEALTHCARE SVCS INCput | $10,433,000 | – | 100,000 | +100.0% | 1.09% | – |
| GH | New | GUARDANT HEALTH INC | $9,658,000 | – | 145,800 | +100.0% | 1.01% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $9,536,000 | – | 18,700 | +100.0% | 0.99% | – |
| EHC | New | ENCOMPASS HEALTH CORP | $8,960,000 | – | 126,000 | +100.0% | 0.93% | – |
| WFC | New | WELLS FARGO CO NEW | $8,723,000 | – | 180,000 | +100.0% | 0.91% | – |
| SNV | New | SYNOVUS FINL CORP | $7,840,000 | – | 160,000 | +100.0% | 0.82% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $7,622,000 | – | 150,000 | +100.0% | 0.79% | – |
| GH | New | GUARDANT HEALTH INCcall | $6,624,000 | – | 100,000 | +100.0% | 0.69% | – |
| QQQ | New | INVESCO QQQ TRcall | $6,344,000 | – | 17,500 | +100.0% | 0.66% | – |
| DFS | New | DISCOVER FINL SVCS | $6,277,000 | – | 56,965 | +100.0% | 0.65% | – |
| New | APOLLO GLOBAL MGMT INC | $6,199,000 | – | 100,000 | +100.0% | 0.65% | – | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCput | $6,058,000 | – | 37,100 | +100.0% | 0.63% | – |
| GILD | New | GILEAD SCIENCES INCput | $5,945,000 | – | 100,000 | +100.0% | 0.62% | – |
| OPTN | New | OPTINOSE INC | $4,940,000 | – | 2,000,000 | +100.0% | 0.52% | – |
| ABT | New | ABBOTT LABS | $4,924,000 | – | 41,600 | +100.0% | 0.51% | – |
| GTLS | New | CHART INDS INC | $4,223,000 | – | 24,585 | +100.0% | 0.44% | – |
| OSTK | New | OVERSTOCK COM INC DEL | $3,080,000 | – | 70,000 | +100.0% | 0.32% | – |
| DOCU | New | DOCUSIGN INCput | $2,678,000 | – | 25,000 | +100.0% | 0.28% | – |
| OSTK | New | OVERSTOCK COM INC DELput | $2,640,000 | – | 60,000 | +100.0% | 0.28% | – |
| DLTR | New | DOLLAR TREE INC | $2,242,000 | – | 14,000 | +100.0% | 0.23% | – |
| TAP | New | MOLSON COORS BEVERAGE COcl b | $2,068,000 | – | 38,750 | +100.0% | 0.22% | – |
| HSY | New | HERSHEY CO | $2,036,000 | – | 9,400 | +100.0% | 0.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.